SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China. - Wikidata - awgldk - TriplyDB

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

http://www.wikidata.org/entity/Q37719675

about

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

http://www.wikidata.org/entity/Q37719675

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

@en

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

@nl

type

label

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

@en

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

@nl

prefLabel

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

@en

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

@nl

P1433

Q37719675-FB160BD3-6837-4537-859B-5DA48C58E41C

P1476

Q37719675-378C832B-F303-4D23-B0E8-11ABD4DFCC05

P2093

Q37719675-3AEC0E3B-E29F-43AE-B798-558A9F31D484

Q37719675-616A0BDC-795D-46BE-91E5-2FC53D95C585

Q37719675-702C635A-12EB-45EA-8CDB-6A2B65BEEDB7

Q37719675-7E5DB086-70FA-450F-B81F-6D04462CDE2E

Q37719675-A55EAFAF-1C5D-49C3-92FB-1F0F148A4EEB

Q37719675-A739DBD2-D6C4-4F0D-B12F-D2B1689B722D

Q37719675-D2DA4A71-AD25-4047-BDE8-E19791B63BC9

Q37719675-DB94B7AE-115B-4F43-BA07-CEE543C3AE8C

P2860

Q37719675-02090559-284A-4A6E-9518-612483A84118

Q37719675-08088992-7323-4C67-9520-04194A8B8097

Q37719675-1E620200-2C00-4D8C-95F8-9C15C3E9BD2D

Q37719675-2A8BD253-24D4-4565-BFBE-5AF3E7BB2668

Q37719675-32B2066B-F41D-4114-B1FF-7EDAB959DBC5

Q37719675-35672EBB-1227-40D9-94F7-FFC58E473049

Q37719675-53FC2F49-3C24-4713-9600-7F1695512C03

Q37719675-6A341B2C-ECCB-4BEE-A126-4B0D6285CD6A

Q37719675-86B705DD-7D74-4FA1-B26C-37982A766198

Q37719675-891BD2EE-9A34-40CF-83F1-A2A135A6EB83

P2888

Q37719675-F813A9DD-B2BF-4771-9473-BE8716603391

P304

Q37719675-D982618C-FD6C-4F7A-8DE9-F74B8968CE7A

P31

Q37719675-70C3C67D-02BC-4054-9BD9-B5839C2E3146

P356

Q37719675-B4197A21-8549-45C8-A527-1A421D3BC24F

P433

Q37719675-B8C4A972-5168-4D19-9A3D-58CBB3583544

P478

Q37719675-CE177183-4857-42FC-AA62-6D49B964B463

P50

Q37719675-1CD6D764-3799-4FB1-BEB3-2EDF6DD97345

P577

Q37719675-6668CF06-73F0-4099-BA9F-873526232704

P6179

Q37719675-0837438E-E7FB-48A5-BE83-B4EEE8745DD9

P698

Q37719675-5572ACC4-D4DC-4348-A9CF-3AADA795EF99

P932

Q37719675-DE0CC5AA-5326-4CEB-B503-0C1CB22B7566

P356

S12985-017-0708-6

P1433

Virology Journal

P1476

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.

@en

P2093

Bin Xu

http://www.w3.org/2001/XMLSchema#string

Hongwei Li

http://www.w3.org/2001/XMLSchema#string

Jiuping Wang

http://www.w3.org/2001/XMLSchema#string

Juan Wang

http://www.w3.org/2001/XMLSchema#string

Liu Yang

http://www.w3.org/2001/XMLSchema#string

Yanhua Li

http://www.w3.org/2001/XMLSchema#string

Yueyun Ma

http://www.w3.org/2001/XMLSchema#string

Yunfeng Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology and genotype distribution of the hepatitis C virus infection

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

Human viruses and cancer.

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.

IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis.

Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection.

Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis

Viral hepatitis and human immunodeficiency virus co-infections in Asia

P2888

s12985-017-0708-6

P304

62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12985-017-0708-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084251613

http://www.w3.org/2001/XMLSchema#string

P698

28335783

http://www.w3.org/2001/XMLSchema#string

P932

5364675

http://www.w3.org/2001/XMLSchema#string